1. Home
  2. ACOG vs PLBY Comparison

ACOG vs PLBY Comparison

Compare ACOG & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • PLBY
  • Stock Information
  • Founded
  • ACOG 2000
  • PLBY 1953
  • Country
  • ACOG Canada
  • PLBY United States
  • Employees
  • ACOG N/A
  • PLBY N/A
  • Industry
  • ACOG
  • PLBY Recreational Games/Products/Toys
  • Sector
  • ACOG
  • PLBY Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • PLBY Nasdaq
  • Market Cap
  • ACOG 130.9M
  • PLBY 139.8M
  • IPO Year
  • ACOG N/A
  • PLBY N/A
  • Fundamental
  • Price
  • ACOG $6.18
  • PLBY $1.84
  • Analyst Decision
  • ACOG Strong Buy
  • PLBY Strong Buy
  • Analyst Count
  • ACOG 1
  • PLBY 1
  • Target Price
  • ACOG $18.00
  • PLBY $3.00
  • AVG Volume (30 Days)
  • ACOG 110.9K
  • PLBY 489.3K
  • Earning Date
  • ACOG 11-13-2025
  • PLBY 11-12-2025
  • Dividend Yield
  • ACOG N/A
  • PLBY N/A
  • EPS Growth
  • ACOG N/A
  • PLBY N/A
  • EPS
  • ACOG N/A
  • PLBY N/A
  • Revenue
  • ACOG $7,427,199.00
  • PLBY $119,510,000.00
  • Revenue This Year
  • ACOG N/A
  • PLBY $5.20
  • Revenue Next Year
  • ACOG $101.16
  • PLBY $8.32
  • P/E Ratio
  • ACOG N/A
  • PLBY N/A
  • Revenue Growth
  • ACOG N/A
  • PLBY N/A
  • 52 Week Low
  • ACOG $3.75
  • PLBY $0.90
  • 52 Week High
  • ACOG $11.54
  • PLBY $2.44
  • Technical
  • Relative Strength Index (RSI)
  • ACOG 47.49
  • PLBY 70.84
  • Support Level
  • ACOG $5.66
  • PLBY $1.57
  • Resistance Level
  • ACOG $6.33
  • PLBY $1.73
  • Average True Range (ATR)
  • ACOG 0.54
  • PLBY 0.11
  • MACD
  • ACOG 0.07
  • PLBY 0.05
  • Stochastic Oscillator
  • ACOG 73.52
  • PLBY 97.46

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: